Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 3 years
- Director since
- 2025
3 years of board service in total across 2 boards, counting each seat separately. Longest: Analog Devices Inc., 1 year.
Analog Devices Inc.
Director
Neogen Corporation
Director
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Analog Devices Inc. March 11, 202699.2%
-
Neogen Corporation October 23, 202591.5%
-
Analog Devices Inc. March 12, 202599.7%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 11, 2026 | Analog Devices Inc. | Grant or award | +747 | — | — |
| Oct 23, 2025 | Neogen Corporation | Grant or award | +19,769 | $6.07 | $119,998 |
| Jun 2, 2025 | Neogen Corporation | Grant or award | +6,090 | $5.69 | $34,652 |
| Mar 12, 2025 | Analog Devices Inc. | Grant or award | +1,160 | — | — |
| Mar 3, 2025 | Abbott Laboratories | Open-market sale | −949 | $138.17 | $131,123 |
| Feb 28, 2025 | Abbott Laboratories | Shares withheld for tax | −7,313 | $135.87 | $993,617 |
| Feb 25, 2025 | Abbott Laboratories | Grant or award | +12,278 | — | — |
| Feb 29, 2024 | Abbott Laboratories | Shares withheld for tax | −8,339 | $120.05 | $1,001,097 |
| Feb 23, 2024 | Abbott Laboratories | Option exercise | +12,500 | $59.94 | $749,250 |
| Feb 23, 2024 | Abbott Laboratories | Open-market sale | −12,500 | $120.00 | $1,500,000 |
| Feb 21, 2024 | Abbott Laboratories | Grant or award | +13,677 | — | — |
| Jan 29, 2024 | Abbott Laboratories | Option exercise | +25,000 | $44.40 | $1,110,000 |
| Jan 29, 2024 | Abbott Laboratories | Open-market sale | −25,000 | $112.50 | $2,812,500 |
| Jan 29, 2024 | Abbott Laboratories | Option exercise | +17,500 | $59.94 | $1,048,950 |
| Jan 29, 2024 | Abbott Laboratories | Open-market sale | −17,500 | $112.50 | $1,968,750 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.